Dermatology Times' Sunday Crossword: April 6, 2025

Welcome to Dermatology Times' Sunday Crossword, where dermatology knowledge meets fun! Each week, we curate a selection of words and terms pulled directly from the latest news in the dermatology world. Whether it's breakthrough treatments, new research findings, or emerging trends, this crossword serves as both a challenge and an opportunity to reinforce your expertise in the field.

For more in-depth insights, don't forget to check out our Weekly Roundup, where we break down the most important stories and updates from the past week. And to stay ahead of the curve and prepare for future crosswords, make sure to follow our content throughout the week.

Try out either our interactive crossword or a static/non-interactive version below.

Interactive Crossword

This crossword was created with CrosswordLabs.com.

Static/Non-Interactive Crossword

Across

5. Plant-derived ingredient used in a dandruff and erythema shampoo.

6. (Brand name) The first IL-23 inhibitor shown to impact both symptoms and structural progression in psoriatic arthritis.

8. Process flagged for underreported adverse drug withdrawal events.

9. Device modality shown effective for facial acne scars in Asian patients.

Down

1. Quality of life metric improved by this fixed-dose aerosol foam in psoriasis.

2. Topical JAK inhibitor with minimal systemic absorption in chronic hand eczema.

3. Condition linked to lower infection risk in recent study.

4. (Abbreviated) Upcoming annual meeting focused on atopic dermatitis research.

7. (Abbreviated) Rare autoimmune blistering disease highlighted in pediatric multicenter study.

10. (Abbreviated) Skin cancer found in a sun-protected area in epidermodysplasia verruciformis.

For answers to this week's puzzle, check out next week's edition of the Dermatology Times Sunday Crossword.

Answers from our March 30, 2025 puzzle: [Across: 4- Xyngari; 5 - neomycin; 6 - melanoma; 9 - nanoparticles; 11 - retinol; Down: 1 - ketoconazole; 2 - adapalene; 3 - delgocitinib; 7 - CRISPR; 8 - IL-17; 10 - atopic]